From humanized models to SubQperior™ panels, we provide the in vivo tumor models and immunophenotyping services you need to evaluate immune responses, optimize therapies, and drive preclinical success.
Leverage human-derived tumor tissue to replicate immune interactions, enabling immunotherapy testing that delivers insights into drug action, kinetics, and toxicity.
Test your immunotherapies against human targets in immunocompetent mice, enabling rapid and reliable preclinical efficacy and safety evaluations.
Explore in vivo tumor models with optimized tumor microenvironments, ideal for testing drug efficacy and immune interactions in immunocompetent hosts.
Enhance oncology studies with SubQperior™, providing homogeneous growth, reduced ulceration, and extended treatment windows over traditional subcutaneous models.
Refine your therapy with proprietary MDI immuno-oncology models designed to preserve tumor cells, stroma, and the tumor microenvironment through in-mouse propagation.
Investigate immune responses with advanced tools like flow cytometry, multiplexed biomarker assays, immunohistochemistry, and TMAs for precise immunotherapy insights.
Tailored Solutions: Customize and build your perfect study with diverse in vivo tumor models and expert support for therapeutic evaluations.
Actionable Insights: Leverage cutting-edge immunophenotyping and immune profiling to evaluate efficacy and immune responses confidently.
Seamless Collaboration: Partner with expert scientists to ensure efficient communication and reproducible results supported by detailed reports.
Proven Reliability: Backed by decades of experience, we deliver data you can trust to accelerate your immunotherapy development.
Partner with Reaction Biology to leverage cutting-edge immuno-oncology models and expert guidance for your preclinical research. Contact us to get started.
